INS and cardiovascular disorder: These data indicate that hepatic CEACAM1 expression is necessary and sufficient to maintain insulin and metabolic homeostasis, and to protect against insulin resistance and its consequences, as well as cardiovascular disease elicited by metabolic inflammation.